SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-028261
Filing Date
2023-06-05
Accepted
2023-06-05 10:56:53
Documents
12
Period of Report
2023-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054000_8k.htm   iXBRL 8-K 46383
  Complete submission text file 0001140361-23-028261.txt   182794

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20230601.xsd EX-101.SCH 3874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230601_lab.xml EX-101.LAB 22546
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230601_pre.xml EX-101.PRE 16050
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054000_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 23991541
SIC: 2834 Pharmaceutical Preparations